NCT06498635 2026-03-18Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialNational Cancer Institute (NCI)Phase 3 Recruiting306 enrolled